✨ Your Portfolio is fetched and updated from zerodha.
Pharmaceuticals
Market Cap
₹0 Cr.
P/E
0.00

Insufficient data

FAQs on Rubicon Research Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Rubicon Research is 0

Growth Table
  • Rubicon Research Ltd.
  • Bandaram Pharma Pack
  • Bal Pharma
Balance Sheet
  • Rubicon Research Ltd.
  • Bandaram Pharma Pack
  • Bal Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Rubicon Research Ltd.
  • Bandaram Pharma Pack
  • Bal Pharma
Cash Flow
  • Rubicon Research Ltd.
  • Bandaram Pharma Pack
  • Bal Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Rubicon Research Ltd.
  • Bandaram Pharma Pack
  • Bal Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Rubicon Research Ltd. Financials

Rubicon Research balance sheet is weak and might have solvency issues

Yes, The debt of Rubicon Research is increasing.
Latest debt of Rubicon Research is ₹280 Crs as of Mar-24.
This is greater than Mar-23 when it was ₹200 Crs.

Yes, profit is increasing.
The profit of Rubicon Research is ₹91.01 Crs for Mar 2024, -₹16.89 Crs for Mar 2023 and -₹67.12 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Rubicon Research latest dividend payout ratio is 0.33% and 3yr average dividend payout ratio is 0.33%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech